Related references
Note: Only part of the references are listed.Immunogenicity and safety of a live attenuated varicella vaccine in children 1-12 years of age: A randomized, blinded, controlled, non-inferiority phase 3 clinical trial
Feng Jiang et al.
CONTEMPORARY CLINICAL TRIALS (2021)
Burden of varicella in the Asia-Pacific region: a systematic literature review
Anne Eng Neo Goh et al.
EXPERT REVIEW OF VACCINES (2019)
Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial
B. Hao et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review
Jessica Leung et al.
EXPERT REVIEW OF VACCINES (2017)
Global Varicella Vaccine Effectiveness: A Meta-analysis
Mona Marin et al.
PEDIATRICS (2016)
Universal varicella vaccine immunization in Japan
Tetsushi Yoshikawa et al.
VACCINE (2016)
Serological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent Assay
Jian Liu et al.
SCIENTIFIC REPORTS (2016)
Varicella zoster virus infection
Anne A. Gershon et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Concomitant administration of hepatitis A vaccine with measles/mumps/rubella/varicella and pneumococcal vaccines in healthy 12-to 23-month-old children
Robert J. Yetman et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
A general approach for sample size calculation for the three-arm 'gold standard' non-inferiority design
Kathrin Stucke et al.
STATISTICS IN MEDICINE (2012)
Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children
Zhi-Lun Zhang et al.
VACCINE (2012)
Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine When Coadministered With Measles-mumps-rubella and Varicella Vaccines in Children Less Than 2 Years of Age
Stephen Rinderknecht et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial
Timo Vesikari et al.
VACCINE (2011)
Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive®):: A double-blind, randomized and controlled trial
Wei-Ping Jiang et al.
VACCINE (2008)
Share Paper
